News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
42,054 Results
Type
Article (2615)
Company Profile (45)
Press Release (39393)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14495)
Career Advice (79)
Deals (2188)
Drug Delivery (9)
Drug Development (4261)
Employer Resources (10)
FDA (616)
Job Trends (798)
News (20977)
Policy (1117)
Tag
Academia (150)
Allergies (7)
Alliances (3580)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (618)
Artificial intelligence (31)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (490)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (44)
Cancer (325)
Cardiovascular disease (11)
Career advice (67)
Career pathing (1)
CAR-T (31)
CDC (1)
Cell therapy (81)
Cervical cancer (2)
Clinical research (3534)
Collaboration (200)
Company closure (2)
Compensation (104)
COVID-19 (186)
CRISPR (11)
C-suite (112)
Cystic fibrosis (7)
Data (432)
Denatured (6)
Depression (11)
Diabetes (18)
Diagnostics (493)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (10)
Duchenne muscular dystrophy (40)
Earnings (4580)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6565)
Executive appointments (134)
FDA (775)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (170)
Gene editing (32)
Generative AI (1)
Gene therapy (55)
GLP-1 (66)
Government (161)
Guidances (24)
Healthcare (737)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (4)
Infectious disease (198)
Inflammatory bowel disease (16)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (26)
Interviews (7)
IPO (1034)
IRA (7)
Job creations (295)
Job search strategy (63)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (52)
Leadership (3)
Legal (226)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (519)
Medtech (520)
Mergers & acquisitions (1273)
Metabolic disorders (75)
Multiple sclerosis (22)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (164)
NextGen: Class of 2026 (364)
Non-profit (156)
Now hiring (11)
Obesity (34)
Opinion (17)
Ovarian cancer (17)
Pain (24)
Pancreatic cancer (21)
Parkinson's disease (11)
Partnered (4)
Patents (54)
Patient recruitment (27)
Peanut (1)
People (5993)
Pharmaceutical (5)
Phase 1 (1499)
Phase 2 (1760)
Phase 3 (937)
Pipeline (396)
Policy (16)
Postmarket research (32)
Preclinical (661)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (15)
Rare diseases (62)
Real estate (430)
Recruiting (5)
Regulatory (971)
Reports (7)
Research institute (153)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (21)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (509)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (52)
Venture capital (15)
Weight loss (22)
Women's health (10)
Worklife (1)
Date
Last 7 days (39)
Last 30 days (153)
Last 365 days (2449)
2026 (212)
2025 (2478)
2024 (2684)
2023 (2964)
2022 (3994)
2021 (4254)
2020 (3634)
2019 (2167)
2018 (1658)
2017 (1900)
2016 (1699)
2015 (1949)
2014 (1450)
2013 (1252)
2012 (1454)
2011 (1383)
2010 (1235)
Location
Africa (44)
Alabama (3)
Arizona (19)
Asia (2139)
Australia (312)
California (1627)
Canada (243)
China (80)
Colorado (54)
Connecticut (18)
Delaware (5)
Europe (4222)
Florida (66)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (2)
Indiana (60)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (49)
Massachusetts (580)
Michigan (14)
Minnesota (25)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (135)
New York (83)
North Carolina (131)
Northern California (787)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (115)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (667)
Tennessee (4)
Texas (152)
United States (3260)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
42,054 Results for "lumen bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Lumen Bioscience awarded $16.2 million in DoD funding to advance LMN-201 through late-stage trials
Lumen Bioscience—a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, announced it was awarded $16.2 million by the U.S. Department of Defense to advance LMN-201 through late-stage trials.
October 17, 2023
·
3 min read
FDA
Lumen Bioscience Receives Fast Track Designation from U.S. FDA for LMN-201
Lumen Bioscience today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for LMN-201, an investigational, orally delivered biologic drug to treat and prevent C. difficile infection (CDI).
May 17, 2023
·
4 min read
BioForest
Lumen Bioscience Details 2022 Company and Facilities Growth, New Funding, and Clinical Pipeline Progress
Lumen Bioscience provided a review of the company’s 2022 growth, including progress in its clinical development programs, GMP manufacturing expansion, and funding.
January 5, 2023
·
5 min read
Press Releases
Think Bioscience Raises $55M in Oversubscribed Series A
January 21, 2026
·
2 min read
BioForest
Lumen Bioscience Awarded $8.8 million from U.S. Department of Defense to Develop Fast-Acting, Intranasal Countermeasure Against Respiratory Viruses
Lumen Bioscience today announced a new $8.8 million project funded by the U.S. Department of Defense (DOD) to develop and test a prototype broad-spectrum, fast-acting intranasal powder for treatment and prevention of known and emerging viral respiratory infections.
May 11, 2023
·
2 min read
Press Releases
Change in Number of Shares and Votes in Alligator Bioscience AB
February 1, 2026
·
1 min read
Press Releases
Imbed Biosciences Secures Strategic Investment from BioLab Holdings
February 4, 2026
·
2 min read
Press Releases
Invitation to Alligator Bioscience’s Earnings Call on 12 February 2026
February 5, 2026
·
1 min read
Press Releases
Genflow Biosciences PLC Announces Directorate Change
January 19, 2026
·
6 min read
Press Releases
Droplet Biosciences-Study Reveals Post-Surgical Lymph Fluid as a Powerful Source of ctDNA for Early Recurrence Detection in Head & Neck Cancer
November 14, 2025
·
4 min read
1 of 4,206
Next
